Cetera Investment Advisers
FLNA

Cetera Investment Advisers’s Filana Therapeutics FLNA Stock Holding History

Cetera Investment Advisers’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.4K Sell
14,466
-2,423
-14% -$4.99K ﹤0.01% 4645
2025
Q4 		$33.4K Buy
16,889
+126
+0.8% +$403 ﹤0.01% 4547
2025
Q3 		$48.8K Buy
16,763
+2,758
+20% +$6.34K ﹤0.01% 4431
2025
Q2 		$25.3K Buy
14,005
+304
+2% +$541 ﹤0.01% 4012
2025
Q1 		$20.6K Buy
13,701
+1,553
+13% +$3.92K ﹤0.01% 3912
2024
Q4 		$28.7K Sell
12,148
-30,406
-71% -$534K ﹤0.01% 3693
2024
Q3 		$1.25M Buy
42,554
+4,664
+12% +$107K ﹤0.01% 1958
2024
Q2 		$468K Buy
37,890
+18,108
+92% +$382K ﹤0.01% 2647
2024
Q1 		$401K Buy
+19,782
New +$456K ﹤0.01% 2786

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Cetera Investment Advisers's FLNA Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Filana Therapeutics (FLNA) stake by 14% in Q1 2026, selling an estimated $4.99K and leaving 14,466 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4645.

Cetera Investment Advisers first reported a position in FLNA in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.25M in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Cetera Investment Advisers held 14,466 shares of Filana Therapeutics worth $24.4K as of Q1 2026.
  • Cetera Investment Advisers sold 2,423 Filana Therapeutics shares in Q1 2026, an estimated $4.99K.
  • Filana Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4645 holding.
  • Cetera Investment Advisers first reported a position in Filana Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Cetera Investment Advisers's Filana Therapeutics position peaked at $1.25M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.